Search results (473)
« Back to NewsHeavier drinking linked to higher levels of harmful “hidden” fat, study finds
25 March 2026
A study of more than 5,700 adults suggests that higher alcohol consumption is associated with increased levels of visceral fat - the type of fat stored deep inside the abdomen and linked to poorer health outcomes.
Paul Leeson named NIHR Senior Investigator
24 March 2026
Professor Paul Leeson is one of seven academics in the University of Oxford's Medical Sciences Division who have been named National Institute of Health Research (NIHR) Senior Investigators. This award recognises the most prominent and prestigious researchers of applied health and social care.
Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment
23 March 2026
Oxford University spinout Dark Blue Therapeutics has been acquired by global biotechnology company Amgen in a deal worth up to US$840 million, marking a major milestone for Oxford-led cancer research and innovation. The deal reflects years of collaborative, multidisciplinary work across the University and its partners to translate fundamental research into promising new medicines.
RDM Day 2026: Celebrating scientific excellence and collaboration
18 March 2026
RDM Day, held on Tuesday 17 March at the Mathematical Institute, brought together researchers, professional services staff and students from across the Radcliffe Department of Medicine for a full day of science, networking and community building.
Paresh Vyas receives CRUK Discovery Programme Award
11 March 2026
Congratulations to Professor Paresh Vyas, who has been awarded a Discovery Research grant from Cancer Research UK to investigate cancer immunotherapies.
Congratulations to 2025 RDM Graduate Citizenship Award Winners
12 February 2026
Congratulations to the winners of the 2025 RDM Graduate Citizenship Award; Casey Johnson and Alexander Redmond.
Night-time changes in metabolism may be driving common liver disease
12 January 2026
Researchers at the University of Oxford have discovered that the most common liver disease follows a strong day-night pattern, and the metabolic changes that drive the disease are most pronounced overnight, when the body is least able to process sugar and fat.
It's beginning to look a lot like Gutmas!
28 November 2025
Congratulations to Vy Wien Lai, whose image was chosen for 1st place in the MRC/MRF 2025 Festive Science Image Competition.
RDM Careers Day 2025: exploring pathways within and beyond academia
26 November 2025
The Researcher Association’s annual RDM Careers Day returned on Thursday 20 November 2025, bringing together DPhil students, postdoctoral researchers and research staff from across RDM for a day of reflection, inspiration, and practical advice.
Professor James Chalmers to join the Radcliffe Department of Medicine
17 November 2025
We are delighted to announce that Professor James Chalmers has been recruited to the statutory Rhodes Professorship of Experimental Therapeutics and Clinical Pharmacology at the University of Oxford. Professor Chalmers is currently GSK/Asthma and Lung UK Professor of Respiratory Medicine at the University of Dundee.
Oxford scientists map the cells that drive Crohn’s disease fistulas
12 November 2025
Researchers at the MRC Translational Immune Discovery Unit have identified how rare populations of abnormal cells drive the formation and persistence of fistulas - painful, tunnel-like tracts that develop in around 30% of people with Crohn’s disease - paving the way for targeted treatments.
Abdullah Khan receives Wellcome Career Development Award
4 November 2025
Congratulations are in order for Dr Abdullah (Abs) Khan, who has been awarded a Wellcome Career Development Award for his research on age-related immune dysfunction using human model systems.
Professor Ellie Tzima receives Leducq Foundation funding to tackle Peripheral Artery Disease
28 September 2025
Professor Ellie Tzima from the Radcliffe Department of Medicine has joined an international team of scientists awarded an $8.5 million grant from the Leducq Foundation to study Peripheral Artery Disease (PAD) and accelerate the development of new therapies.
Oxford University to accelerate type 1 diabetes research and care with £10 million gift
25 September 2025
The University of Oxford has announced a gift of £10 million from the Bukhman Foundation to support ground-breaking research into type 1 diabetes (T1D). This generous funding will establish the Bukhman Centre for Research Excellence in Type 1 Diabetes, as well as create new academic posts and scholarships, helping to accelerate progress towards better treatments and ultimately a cure.
DPhil sponsorship agreement with medical university and hospital /medical centre in Taiwan
29 August 2025
On 28 August, RDM signed a Memorandum of Understanding with the National Defense Medical University and Tri-Service General Hospital in Taiwan which will provide funding for their students who have successfully enrolled on the DPhil in Medical Sciences.
‘Targeted Therapies’ at Big Bang Fair 2025
20 August 2025
Earlier this year, a group of researchers from the MRC Weatherall Institute of Molecular Medicine attended the Big Bang Fair in Birmingham, showcasing medical research through a series of hands-on activities.
Platelets shown to store DNA in study that could transform cancer screening
15 August 2025
Study led by Psaila Group uncovers previously unknown function of platelets as DNA ‘vacuum cleaners’ in the blood, with profound implications for cancer diagnosis and prenatal screening.